|
|
|
 |
Facts to Know
|
Click here to download or order the NWHRC's Women's Health Updates: "Hormone Therapy Options: Bioidentical Hormones"
|
|
Learn more about sexuality and sexual wellness during and after menopause from Nurture Your Nature--a joint project of the NWHRC and ARHP
|
| Visit NWHRC's sexuality center, a resource for women seeking timely information about female sexuality. |
Estrogen is produced in the ovaries, adrenal glands and fat tissues. It
prepares the reproductive organs for conception and pregnancy. Estriol, a
form of estrogen, is produced by the placenta during pregnancy.
The function of estrogen in the body is complex. We have learned a lot,
but there is still much more to learn.
Declining or low levels of estrogen can cause physical symptoms including
hot flashes night sweats and vaginal dryness.
By the time you reach menopause, you will produce only about one-third the
amount of estrogen you produced during your childbearing years.
Supplemental estrogen taken after menopause does not appear to prevent heart
disease when initiated in older women several years past menopause.
The U.S. Food and Drug Administration and other agencies have adopted new
terminology to describe hormone regimens used to replace hormones that decline
with the onset of menopause or are deficient as a result of medical conditions.
The term, "replacement" has been dropped from "hormone replacement
therapy." Instead, estrogen-only therapy is called estrogen therapy,
or ET, and estrogen/progestin or estrogen/progesterone therapy is called hormone
therapy, or HT.
The term "estrogen" includes a group of closely related compounds,
including estradiol, estrone and estriol.
Estrogen therapy may be prescribed for conditions such as delayed onset
of puberty, genital atrophy, or female hypogonadism (incomplete functioning
of the ovaries, creating symptoms such as vaginal dryness, breast atrophy
and lower sex drive).
There is new evidence that long-term use of estrogen alone therapy may increase
a women's risk of ovarian cancer.
New findings from a memory sub-study of the Women's Health Initiative (WHI)
indicate that women who are older than 65 when they start taking combination
hormone therapy have an increased risk of developing dementia, including Alzheimer's
disease, compared with women who do not take the medication.
| |
|
View References for this Health Topic
|
Create Date: 2/20/02
Date Last Updated: 3/15/06
Review Date: 1/16/06
|
|
| |
|
|
|